Recombinant Human BHMT Protein，His

Betaine-homocysteine S-methyltransferase (BHMT) is a crucial enzyme involved in the methylation cycle, which plays a significant role in transferring methyl groups to homocysteine to form methionine, an essential amino acid. The study of recombinant BHMT is driven by its potential implications in human health, particularly in relation to cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes that are linked to homocysteine levels. Elevated homocysteine is implicated in various pathologies, including atherosclerosis and Alzheimer's disease, underscoring the importance of understanding BHMT's function in regulating homocysteine metabolism. Recombinant BHMT can be produced using various expression systems, allowing researchers to investigate its biochemical properties, enzymatic activity, and regulatory mechanisms in detail. Additionally, the recombinant form provides a valuable tool for studying the effects of genetic variations in the BHMT gene and their association with disease susceptibility. Understanding the structure and function of BHMT may pave the way for novel therapeutic strategies aimed at modulating homocysteine levels and improving clinical outcomes in affected individuals. The development of BHMT as a recombinant protein also has implications in the fields of metabolic engineering and synthetic biology, where it could potentially be utilized in designing biotechnological applications that enhance methylation processes in various organisms. Overall, the research on recombinant BHMT is essential for elucidating its biological significance and potential as a target for therapeutic intervention, highlighting its relevance in the study of human health and disease.